You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Harvard Business School
Colorcon
Dow
Moodys

Last Updated: April 11, 2021

DrugPatentWatch Database Preview

Litigation Details for GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA (D. Del. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2016-04-12 110 Amended Infringement Contentions for U.S. Patent No. RE40,000 Against Defendant Glenmark Pharmaceuticals… 3 July 2014 1:14-cv-00877 830 Patent Plaintiff District Court, D. Delaware External link to document
2016-06-03 133 indirectly infringe U.S. Patent No. RE40,000 (the "'000 patent"). Presently before the…assignment, of the '000 patent, and GlaxoSmithKline LLC is the patent's exclusive licensee. (Id…, ex. B) Citation to the patent will simply be to the "'000 patent." … '000 Patent In June 1995, GSK and its research partner filed a patent application directed…CHF, which issued as U.S. Patent No. 5,760,069 (the '"069 patent") entitled "Method External link to document
2016-09-19 159 ., M.P.H. Regarding Infringement of U.S. Patent No. RE40,000 by Glenmark Pharmaceuticals, Inc. USA; (3… 3 July 2014 1:14-cv-00877 830 Patent Plaintiff District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
AstraZeneca
McKesson
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.